Specific insoluble protein aggregates are the hallmarks of many neurodegenerative diseases [1] [2] [3] [4] [5] . For example, cytoplasmic aggregates of the RNA-binding protein are observed in 97% of cases of Amyotrophic Lateral Sclerosis (ALS) 6, 7 . However, it is still unclear for ALS and other diseases whether it is the insoluble aggregates or other forms of the mutated proteins that cause these diseases that are actually toxic to cells [8] [9] [10] [11] [12] [13] . Here we address this question for TDP-43 by systematically mutating 14 the protein and quantifying the effects on cellular toxicity. We generated >50,000 mutations in the intrinsically disordered prion-like domain (PRD) and observed that changes in hydrophobicity and aggregation potential are highly predictive of changes in toxicity.
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Main text
The conversion of specific proteins into insoluble aggregates is a hallmark of many neurodegenerative disorders, including Alzheimer's, Parkinson's, Huntington's, and Amyotrophic Lateral Sclerosis (ALS) with dominantly inherited mutations in aggregateforming proteins causing rare familial forms of these diseases 3, 6, 15 . However, both in humans and in animal models, there is often only a weak association between the presence of aggregates and disease progression 16, 17 . Indeed, many therapeutic approaches that reduce the formation of aggregates have failed at different stages of development 12, 18, 19 . On the other hand, there is increasing evidence that alternative protein assemblies generated during or in parallel to the aggregation process, may be toxic [8] [9] [10] [11] 20 . Despite evidence that cellular damage may be induced either before, after or independent of the formation of insoluble aggregates, the latter are still widely assumed to be pathogenic in many neurodegenerative diseases 21, 22 .
For many proteins, aggregation depends critically on intrinsically disordered regions with a low sequence complexity resembling that of infectious yeast prions. These prion-like domains (PRDs) are also enriched in proteins that can form liquid-like cellular condensates [23] [24] [25] with the PRDs necessary and sufficient for liquid-demixing 26, 27 . At least in vitro, insoluble aggregates can nucleate from more liquid phases [27] [28] [29] , leading to the suggestion that liquid de-mixed states can mature into pathological aggregates 22 .
Disordered regions 30 and low complexity sequences 31 are also enriched in dosagesensitive proteins -those that are toxic when their concentration is increased. At least for one model protein that has been tested, however, it is the formation of a concentrationdependent liquid-like phase -not aggregation -that causes cellular toxicity 31 . Similarly, the toxicity of two mutant forms of the prion Sup35 could be explained only on the basis of their ability to populate a non-aggregate, liquid-like state 23, 32 .
Cytoplasmic aggregates of the RNA-binding protein TDP-43 are a hallmark of ALS, present in 97% of post-mortem samples 6, 7 . TDP-43 aggregates are also present at autopsy in nearly all cases of frontotemporal dementia (FTD) that lack tau-containing inclusions (about half of all cases of FTD which is the second most common dementia) 33 . TDP-43 aggregates are also a hallmark of inclusion body myopathy and a secondary pathology in Alzheimer's, Parkinson's, and Huntington's disease [33] [34] [35] .
However, TDP-43 aggregates are also observed -albeit at low frequency -in control samples 36 and, in vitro, TDP-43 can form both amyloid aggregates and liquid condensates [37] [38] [39] [40] [41] . Mutations in TDP-43 cause ~5% of familial ALS cases 17, 42 , with these 4 mutations clustered in the PRD and reported to interfere with nuclear-cytoplasmic transport, RNA processing, splicing, and protein translation 16, [43] [44] [45] [46] [47] [48] . However, despite extensive investigation, the molecular form of the protein that causes cellular toxicity is still unknown 16, 49 .
We reasoned that systematic ('deep') mutagenesis could be an unbiased approach to identify and investigate the toxic species of proteins 14, 50, 51 . A map of which amino acid changes increase or decrease the toxicity of a protein to a cell should, if sufficiently comprehensive, clarify both the properties of the protein and its in vivo structural conformations associated with toxicity 52 . The effects of a small number of mutations on TDP-43 toxicity or aggregation have been previously reported 10, 37, [53] [54] [55] [56] . However, on the basis of a handful of mutations, the relationship between aggregation and toxicity is far from clear.
We used error-prone oligonucleotide synthesis to comprehensively mutate the PRD of TDP-43. We introduced the library into yeast cells, induced expression and used deep sequencing before and after induction to quantify the relative effects of each variant on growth in three biological replicates (Fig. 1a ). After quality control and filtering (ED Fig. 1a-c), the dataset quantifies the relative toxicity of 1,266 single and 56,730 double amino acid (AA) changes in the PRD with high reproducibility (Fig. 1b, ED Fig. 1d ,e). The toxicity scores also correlate very well with the toxicity of the same variants re-tested in the absence of competition (Fig. 1c) .
The toxicity of both single and double mutants had a tri-modal distribution ( Plotting the mean toxicity of all mutations at each position in the sequence reveals a 31
AA hotspot (312-342) where the effects of mutations are strongest (Fig. 1e) . The variance in toxicity per position is also the highest within this hotspot, with mutations both strongly increasing and decreasing toxicity (Fig. 1e) . A heatmap of the toxicity of all of the single mutations also clearly reveals this hotspot, with most mutations of strong positive or negative effect falling within this 31 AA window (Fig. 1f) . Equally strikingly, mutations to the same AA but in different positions within the hotspot often have very similar effects
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( Fig. 1f) . In particular, mutations to charged and polar residues increase toxicity throughout the hotspot and mutations to hydrophobic amino acids decrease toxicity (Fig.   1f ).
To more systematically identify features associated with changes in toxicity we made use of all 53,468 variants carrying one or two AA substitutions. We used principal components analysis (PCA) to reduce the redundancy in a list of over 350 AA physicochemical properties (ED Fig. 3 ) and linear regression to quantify how well changes in these physicochemical properties predict changes in the toxicity of TDP-43. A principal component very strongly related to hydrophobicity is the most predictive feature of toxicity, explaining 66% of the variance in toxicity of all 8,040 mutants within the 312-342 hotspot and 51% of the variance in toxicity of all genotypes (Fig. 2a) .
With the same approach we tested the performance of established predictors of protein aggregation, intrinsic disorder and other properties. None of them are as predictive as hydrophobicity (Fig. 2b, c) . Importantly, after controlling for hydrophobicity, additional features such as charge and aromaticity do not predict toxicity (Fig. 2d , e, ED Fig. 4a ) with aggregation potential accounting for an additional 4% of variance in the hotspot (Fig. 2f, g ).
That increased hydrophobicity and aggregation potential are strongly associated with reduced toxicity across >50,000 genotypes was unexpected given previous work that reported an increased number of intracellular aggregates for a set of TDP-43 variants toxic to yeast 55 and the widely-held view that aggregation is harmful to cells 44, 53, 57 . We therefore further investigated the effects of mutants that alter the hydrophobicity and toxicity of TDP-43.
WT TDP-43 localizes to both the nucleus and to the cytoplasm of yeast cells 55, 56 (Fig.   3a ). In the nucleus, TDP-43 is diffuse, but in the cytoplasm it forms puncta, consistent with previous observations 43, 58 . We observed that cytoplasmic WT TDP-43 forms two types of assemblies: small foci in the nuclear periphery and larger foci detached from the nucleus (Fig. 3a-c) . We found that mutations that decrease TDP-43 hydrophobicity and increase TDP-43 toxicity increase the number of the small foci at the nuclear periphery and reduce the number of large distal foci (Fig. 3b , c, f, ED Fig. 5a ). In contrast, mutations that increase hydrophobicity and reduce toxicity reduce the number of small nucleus-associated foci and increase the number of large distal foci (Fig. 3b , c, f, ED Fig.   5a ).
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We used fluorescence recovery after photobleaching (FRAP) to characterize the dynamics of TDP-43 variants in the different foci. The large cytoplasmic foci formed by non-toxic variants show little exchange of TDP-43 molecules with the soluble cytoplasmic pool. In contrast, the small foci localized at the nuclear periphery can exchange more protein with the cytoplasm, consistent with a more liquid-like state (Fig. 3d, e ). Such differences in dynamics have been previously described for distinct types of misfolded protein compartments 59 . The large immobile TDP-43 foci are also brighter than the small dynamic ones (Fig. 3g) , similar to what has been observed for Huntingtin variants that partition between immobile bright assemblies and liquid-like dimmer ones 60 . The nontoxic TDP-43 variants also had a higher protein concentration quantified by Western blotting (ED Fig. 5b ).
Taken together, these results suggest that mutations that increase the hydrophobicity of TDP-43 result in a re-localization of the protein away from small and dynamic, liquid-like foci at the nuclear periphery to large and more solid aggregates in the cytoplasm. A reduction in hydrophobicity has the opposite effect.
The hotspot region of the TDP-43 PRD (AA 312-342) contains a conserved region 37, 38 , with hydrophobicity more similar to the globular domains of TDP-43 than to the surrounding hydrophilic disordered regions (Fig. 4b) . The hotspot is contained within a region (311-360) that was previously shown to be sufficient for both in vitro aggregation and the formation of cytoplasmic foci 37 . Fragments from within this region have previously been shown to have the potential to form different types of secondary structures in vitro.
More specifically, nuclear magnetic resonance (NMR) spectroscopy of the PRD revealed that residues 321-342 can adopt an -helical structure in certain conditions 37, 38, 49 and four different 6-11 AA peptides from the region could form cross-β amyloid or amyloidlike fibrils whose structures were determined by X-ray crystallography 53 . However, it is unknown whether any of these structures exist in vivo for full length TDP-43.
We have shown recently that the pattern of genetic (epistatic) interactions between mutations in a protein can determine the structure of that molecule when it is performing the function that is being selected for 52 . In particular, when a sequence forms an -helix, the side chains of residues separated by 3-4 AA are close in space and similarly oriented so that mutations in these AA interact similarly with mutations in the rest of the protein.
In contrast, in a β -strand, the side chains of residues separated by 2 AA are close and similarly oriented and so make similar genetic interactions with other mutations (Fig. 4a ).
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We used 52,272 double mutants (excluding STOP codon variants) in our dataset to identify pairs of mutations that genetically interact. We first identified pairs of mutations that had unexpectedly high or low toxicity (<5 th and >95 th percentile of the expected toxicity distribution, negative and positive epistasis for growth rate, respectively). We then quantified the similarity of epistasis enrichment profiles between pairs of positions and compared these patterns to those expected for -helices and β -strands, scoring significance by randomisation 52 (Fig. 4a ).
This revealed that the patterns of epistasis in our dataset are consistent with two secondary structure elements forming inside the PRD in vivo: a β -strand at residues 311-316 and an -helix at residues 324-331 (Fig. 4c) Phe 316 and Ala 315, which again is compatible with a LARKS but not with a canonical β -strand, has the highest predicted contact score among neighboring residues (Fig. 4d) .
The predicted contact map built on the basis of in vivo epistatic interactions strikingly matches the PDB structure for LARKS 312-317 (Fig. 4d, ED Fig. 6 ).
On the other hand, the genetic interactions of mutations in the 324-330 region match those expected for an -helix (Fig. 4e ). This region is part of the portion (321-342) of TDP-43 that can transiently and cooperatively fold into a -helix in vitro 38, 49, 62 . This helix is stabilized by inter-molecular contacts and its self-interaction was proposed to seed liquid-demixing in vitro. Amyloid fibrils can grow from the liquid de-mixed state and circular dichroism spectroscopy revealed that the helix transitions to a β -sheet over time, compatible with the process of aggregation 37, 62 . On the basis of epistasis, the top scoring predicted contacts in this region are between residues separated by 3-4 AA such as Ala 324 and Ala 328, or Ala 325 and Ala 328, consistent with interactions between side chains of an -helix (Fig. 4e ). 63 .
Mutations in TPD-43 had their strongest effects on toxicity within a hydrophobic region where the patterns of genetic interactions are consistent with the in vivo formation of two structural elements that have been shown to be important for the phase separation and aggregation of fragments of TDP-43 in vitro 38, 49, 53, 62 .
More generally, our results show that deep mutagenesis is a powerful approach for determining the sequence-function relationships of intrinsically disordered proteins, including their in vivo structural conformations. The conformations of 'unstructured'
proteins are notoriously difficult to study and the interactions between mutations in double mutants provide a general method to probe the in vivo structures of these proteins whenever a selection assay is available. We envisage that this approach can be adopted to study the functions, toxicity, and in vivo structures of other intrinsically disordered proteins, including the many other proteins implicated in neurodegenerative diseases.
Our conclusions derived from deep mutagenesis of TDP-43 are also consistent with observations for other ALS genes, including the reduced toxicity of SOD-1 variants that increase aggregation 11, 64 . They are also consistent with the increasing evidence that insoluble aggregates are not pathogenic in multiple other neurodegenerative diseases 4, 65, 66 , and with the clinical failure of therapeutic approaches that reduce 9 aggregation in vitro and in vivo 12, 13, 19, 67, 68 . Indeed, if insoluble aggregates titrate proteins away from alternative toxic phases, then promoting rather than alleviating aggregation might be the appropriate therapeutic goal.
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Methods
Yeast Strains and Plasmids
Saccharomyces cerevisiae S288C BY4741 (MATa his3∆1 leu2∆0 met15∆0 ura3∆0) 
Yeast Transformation and Selection experiments
Yeast cells were transformed with the TDP-43 doped plasmid in 4 independent biological replicates for each library. One single colony was grown overnight in 30 ml After ~50 h of growth, cells were diluted in SC-URA 2% raffinose medium and grown for 4.5 generations. At this stage, 400 mL of each replica were harvested, washed, split into two tubes and frozen at -20ºC for later extraction of input DNA. To induce plasmid expression, for each replicate two cultures were diluted in SC-URA 2% galactose medium. After 5-6 generations, 2X400 mL for each replicate were harvested to obtain output pellets for DNA extraction.
DNA Extraction and Library Preparation
Input and Output pellets were resuspended in 1.5 mL extraction buffer (2% Triton-X, 1% SDS, 100 mM NaCl, 10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0). Two cycles of freezing in an ethanol-ice bath and heating at 62ºC were performed. Deproteinization was performed using 25:24:1 phenol-chloroform-isoamyl alcohol and glass beads.
After centrifugation, the aqueous phase, containing the DNA, was recovered and treated again with phenol-chloroform-isoamyl alcohol. The samples were incubated 30 min at -20ºC with 1:10V 3M NaOAc and 2.2V 100% ethanol for DNA precipitation. At this stage and after centrifugation for 30 min, the pellets were dried overnight at room temperature. RNA was eliminated by incubation with RNAse 10 mg/mL for 30 min at 37ºC. DNA purification was achieved with a QIAEX II Gel Extraction Kit (Qiagen) and DNA was eluted in 375 μL of elution buffer. DNA concentration was measured by q-PCR, with primers annealing to the Ori site of the pRS416 plasmid (Supplementary   Table 1 , primers BB_15, BB_16).
The TDP-43 library was then prepared for deep sequencing by PCR amplification in two steps using Q5 High-Fidelity DNA Polymerase (NEB). In step 1, 300 million plasmids were amplified for 15 cycles using frame-shifted adaptor primers with a partial Assay Kit (Promega). All replicates were pooled together in an equimolar ratio. Finally, the pooled sequencing library was run on a 2% agarose gel, purified and sent for 125 bp paired-end Illumina sequencing at the CRG Genomics Unit.
Individual Growth Rate Measurements
Yeast cells expressing selected TDP-43 variants were grown overnight in SC-URA 2% raffinose non-inducing medium and diluted to 0.2 OD 600 nm until exponential phase.
Then they were diluted to 0.1 OD 600 nm in SC-URA 2% galactose to asses growth in inducing conditions. Growth was monitored by measuring OD 600 nm in a 96-well plate at 10 min intervals inside an Infinite M200 PRO microplate reader (Tecan). Plates were kept constantly shaking at 30ºC. Growth curves were fitted in order to extrapolate growth rates that correspond to the maximum sloped of the linear range of the LN(OD) curve over time.
Equipment and Settings
Imaging was performed by using a Confocal TCS SP8 and a Confocal TCS SP5
(Leica) equipped with PMT detectors both for fluorescence and transmitted light images. AOBS beam-splitter systems are in place on both instruments. 63X oil immersion objectives and the LAS AF software were used for all imaging. YFP fluorescence was excited with a 488 nm laser, while mCherry fluorescence with a 561 nm laser. Ranges for emission detection were 495-554 and 637-670 nm respectively.
Image depth is 8-bit in all cases and pixel size equals 120.4 nm. The LUT is linear and covers the full range of the data.
Fluorescence Microscopy and Image Analysis
Yeast cells expressing TDP-43 selected variants were grown in SC-URA 2% raffinose non-inducing medium and then transferred to SC-URA 2% galactose medium to induce protein expression for 8h. They were then imaged under a Confocal TCS SP8 69 .
Protein Extraction and Western Blotting
Single yeast colonies were grown overnight in non-inducing medium and then diluted Sequencing data pre-processing 1 4 FastQ files from paired-end sequencing of replicate deep mutational scanning (DMS) libraries before ('input') and after selection ('output') were processed using a custom pipeline (https://github.com/lehner-lab/DiMSum, manuscript in prep. Fig. 1a, b) .
Variant toxicity and error estimates
All analyses of toxicity were performed on variants with a maximum of two AA mutations, but no synonymous mutations in other codons. Firstly, sample-wise counts for variants identical at the AA level were aggregated. For each replicate selection, relative toxicity of variants was calculated from variant counts in input ‫ܨ(‬ Fig. 2a-c) . Furthermore, we removed low confidence variants supported by an average of less than ten input reads from all downstream analyses.
Simple linear regression models to predict variant toxicity
We used simple linear regression to predict variant toxicity from (i) a collection of AA property features, (ii) a panel of scores from aggregation/structure algorithms and (iii) location with respect to the toxicity hotspot. six-mers to ZipperDB. For the remainder, the full-length AA sequence was used.
Variants inside the hotspot were defined as those with mutant residue positions in the range 312-342. Change in absolute charge (regardless of sign) is shown in Fig. 2d , e, because this feature is more predictive of toxicity than change in charge itself (not shown). For double mutant variants, we summed the feature values of the constituent singles for both AA property and aggregation/structure algorithm features. Regression models were built using either (i) all variants, restricting variants to those occurring either (ii) inside or (iii) outside the toxicity hotspot (for double mutants both mutations have to occur either inside or outside the hotspot region), or (iv) including a binary location variable (0: one/all outside, 1: one inside, one outside, 2: one/all inside toxicity hotspot) and a third term indicating the interaction between location and the AA property or aggregation/structure algorithm feature.
Predicting secondary structure from epistasis
Epistasis is the non-independence of mutation effects, i.e. the toxicity of double mutants is different from that expected given the toxicity of their constituent single mutant variants. We have previously shown that epistasis between double mutants can result from structural interactions within proteins and therefore can be used to infer secondary and tertiary structural features 52 . In brief, double mutants were classified as epistatic if they had more extreme toxicity values (below 5 th percentile or above 95 th percentile) than other double mutants with similar single mutant toxicities, which was estimated from non-parametric surface fits of double mutant toxicity as a function of a two-dimensional single mutant toxicity space (Fig. 4a) .
Double mutants close to the lower or upper measurement range limits (where the power to detect significant epistasis is reduced) were excluded from epistasis quantification. We calculated position-pair enrichments for epistatic double mutants resulting in a pair-wise enrichment matrix. Diagonal entries on this matrix were imputed 1 7 as column-wise mean enrichments. An epistasis correlation score matrix was then derived from this enrichment matrix by calculating the partial correlation of epistasis interaction profiles (columns of the enrichment matrix) between all pairs of positions.
The rationale for the correlation score is that structurally close positions within a protein should have similar epistatic interactions with all other positions in the protein.
Calculating partial correlations additionally removes transitive interactions and was found to be superior over epistasis enrichments in estimating secondary structures 52 .
Secondary structure propensities were calculated by testing for agreement of epistasis correlation score patterns with the stereotypical periodicities of an -helix and β -strand, using two-dimensional kernels at each position along the diagonal of the epistasis correlation score matrix 52 . Significance of secondary structure propensities was assessed by comparison to propensities derived from 10 4 randomized epistasis correlation score matrices.
Similarly, LARKS structure propensities were calculated using PDB-structure derived contact matrices based on a minimal side-chain heavy atom distance of 4.5Å (ED Images were taken on cells growing from at least 3 independent starting colonies.
2 0 * P < 0.05, ** P < 0.01, *** P < 0.001,**** P < 0.0001. 
